ARTICLE
13 August 2021

Executive Stock Sales Are Under Scrutiny. Here's What Regulators Are Interested In

M
Mintz

Contributor

Mintz is a litigation powerhouse and business accelerator serving leaders in life sciences, private equity, sustainable energy, and technology. The world’s most innovative companies trust Mintz to provide expert advice, protect and monetize their IP, negotiate deals, source financing, and solve complex legal challenges. The firm has over 600 attorneys across offices in Boston, Los Angeles, Miami, New York, Washington, DC, San Francisco, San Diego, and Toronto.
The regulators have made it clear that they are revisiting Rule 10b5-1 Executive Stock Sale Plans with a view of "tightening" them up.
United States Corporate/Commercial Law

The regulators have made it clear that they are revisiting Rule 10b5-1 Executive Stock Sale Plans with a view of "tightening" them up.  While we cannot, with specificity, anticipate what the changes will be in connection with existing plans and in connection with new plans, it may be advisable to consider programs which provide for periodic sales or periodic sales with specified prior targets. Such an approach could be expected to make the plans less likely to need to be changed or attacked in the future.

Securities regulators are rethinking rules on popular plans that let corporate executives sell stock without violating insider-trading provisions.

https://www.wsj.com/articles/executive-stock-sales-are-under

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More